Can a simple score predict prostate surgery success?
NCT ID NCT07623239
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will analyze data from 2,000 men who had prostate surgery for an enlarged prostate (BPH). Researchers want to build a scoring system using MRI scans, urine flow tests, and symptom scores to predict who will have a good outcome. The goal is to help doctors and patients decide together whether surgery is worth it.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could give doctors a simple tool to predict which BPH patients will benefit most from surgery, helping avoid unnecessary procedures.
- What could go wrong
- This is an early, retrospective study—not a treatment trial. The scoring system may not work well in other hospitals or countries, and it won't directly improve anyone's health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 2,000 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
This study population consists of adult male patients diagnosed with benign prostatic hyperplasia (BPH) who underwent prostate surgery (including transurethral resection of the prostate, laser enucleation, photoselective vaporization, or robot-assisted simple prostatectomy) between January 1, 2020 and August 30, 2025. Participants were recruited from four hospitals in China: The First Affiliated Hospital of Fujian Medical University, Fujian Medical University Union Hospital, Fuzhou Hospital of Traditional Chinese Medicine, and The First People's Hospital of Yunnan Province. All patients are of Chinese ethnicity and were selected based on the eligibility criteria described above. No specific community-based recruitment or sampling methods were applied; all consecutive eligible patients during the study period were included.
- Ages
-
30 to 100 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * \- Postoperative pathological diagnosis of benign prostatic hyperplasia (BPH) * Completion of pelvic or prostate magnetic resonance imaging (MRI) plain scan within 1 month before surgery * Completion of urodynamic study within 1 month before surgery * Completion of International Prostate Symptom Score (IPSS) both before and after surgery * Complete and retrievable clinical and pathological data * Generally good condition without infection, autoimmune disease, hematologic disease, or other malignancies * Complete follow-up data with follow-up duration of at least 6 months after surgery Exclusion Criteria: * \- Concomitant prostate cancer or other malignancies * Prior prostate surgery or pelvic radiotherapy * Severe cardiac, pulmonary, hepatic, or renal insufficiency precluding tolerance of surgery * Intraoperative or postoperative severe complications affecting efficacy assessment * Follow-up duration less than 6 months or missing key data * Poor patient compliance precluding completion of necessary assessments and follow-up * Incomplete clinical, imaging, urodynamic, or pathological data, or loss to follow-up
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Benign prostatic hyperplasia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One surgery or two? trial tests prostate removal during bladder stone operation
- Laser prostate surgery that spares ejaculation put to a Five-Year test
- Two prostate pills instead of one: can doubling up on alpha blockers clear urine retention?
- Virtual basket laser mode put to the test for faster prostate surgery
- Steam therapy vs. surgery: can a less invasive fix help men with blocked urine flow?
- Can a gel stop bleeding after prostate surgery and send men home the same day?